These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7879252)
61. Consider lipoprotein(a), not just apolipoprotein B, when determining low-density lipoprotein for lipoprotein profiles. Doetsch K Clin Chem; 1990 Oct; 36(10):1857-8. PubMed ID: 2208679 [No Abstract] [Full Text] [Related]
62. Oral physiological magnesium supplementation for 6 weeks with 1 g/d magnesium oxide does not affect increased Lp(a) levels in hypercholesterolaemic subjects. Hoogerbrugge N; Cobbaert C; de Heide L; Birkenhäger JC Magnes Res; 1996 Jun; 9(2):129-32. PubMed ID: 8878009 [TBL] [Abstract][Full Text] [Related]
63. Lipoprotein lipids and apoproteins in healthy renal transplant recipients. Allegra V; Mengozzi G; Vasile A Nephron; 1989; 51(2):276-7. PubMed ID: 2644576 [No Abstract] [Full Text] [Related]
64. [Serum lipoprotein disorders in kala-azar]. Mebazaa A; Kallel R; Boussen H; Ben Rachid MS Tunis Med; 1984; 62(2):149-51. PubMed ID: 6528389 [No Abstract] [Full Text] [Related]
65. [Nutritional intervention in overweight subjects with hypercholesterolemia. Reduction of blood cholesterol by guided diet therapy]. Donini LM; Balotta M; De Felice MR Ann Ig; 1996; 8(5):559-63. PubMed ID: 9244467 [No Abstract] [Full Text] [Related]
66. Lipoprotein(A) levels and apoprotein(a) phenotypes in a Sicilian population. Noto D; Barbagallo CM; Cavera G; Caldarella R; Marino G; Pace A; Notarbartolo A; Averna MR Ann Ital Med Int; 1998; 13(4):205-8. PubMed ID: 10400464 [TBL] [Abstract][Full Text] [Related]
67. Assessment of functional low-density-lipoprotein receptors on lymphocytes by a simplified method using culture medium with lipoprotein-free fetal calf serum and pravastatin. Sakuma N; Iwata S; Ichikawa T; Fujinami T Clin Biochem; 1992 Oct; 25(5):368-70. PubMed ID: 1337022 [No Abstract] [Full Text] [Related]
68. Oxidative stress in renal transplant recipients with chronic rejection: rationale for antioxidant supplementation. Vela C; Cristol JP; Maggi MF; Ribstein J; Mimran A; Descomps B; Mourad G Transplant Proc; 1999; 31(1-2):1310-1. PubMed ID: 10083585 [No Abstract] [Full Text] [Related]
69. A case of 'crouching' triglyceride and 'hidden' cholesterol. Mak CM; Pang RW; Tam S Br J Biomed Sci; 2004; 61(3):152-3. PubMed ID: 15462264 [No Abstract] [Full Text] [Related]
70. The MEGA study. Nango E; Saio T; Yuasa H Lancet; 2006 Dec; 368(9552):2051; author reply 2052. PubMed ID: 17161723 [No Abstract] [Full Text] [Related]
71. [The lipid disturbances in women during climacterium (author's transl)]. Chojnowska-Jezierska J Przegl Lek; 1980; 37(7):547-50. PubMed ID: 7414006 [No Abstract] [Full Text] [Related]
72. What should be done about asymptomatic hypercholesterolaemia? Thompson GR BMJ; 1991 Mar; 302(6777):605-6. PubMed ID: 1826458 [No Abstract] [Full Text] [Related]
73. Serum lipoprotein (a) levels in renal transplantation: role of renal function. Massy ZA; Drüeke T; Kreis H; Lacour B Nephron; 1996; 73(4):718-9. PubMed ID: 8856283 [No Abstract] [Full Text] [Related]
75. The role of leptin in body mass index increase in renal allograft recipients. Baçzkowska T; Soin J; Soluch L; Lao M; Gaciong Z Transplant Proc; 2000 Sep; 32(6):1331-2. PubMed ID: 10995969 [No Abstract] [Full Text] [Related]
76. Magnesium repletion therapy improved lipid metabolism in hypomagnesemic renal transplant recipients: a pilot study. Gupta BK; Glicklich D; Tellis VA Transplantation; 1999 Jun; 67(11):1485-7. PubMed ID: 10385091 [TBL] [Abstract][Full Text] [Related]
77. Cyclosporin and serum lipids in renal transplant recipients. Irish A Lancet; 1993 Mar; 341(8847):766; author reply 767. PubMed ID: 8095675 [No Abstract] [Full Text] [Related]